Cargando…
Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology
RATIONALE: Hepatitis E is an infectious disease due to inflammation of the liver caused by hepatitis E virus (HEV) and represents one of the most common causes of acute hepatitis and jaundice in the world. Although data of hepatitis E infection in patients with rheumatoid arthritis (RA) are accumula...
Autores principales: | Carubbi, Francesco, Picchi, Giovanna, Di Bartolomeo, Salvatore, Ricciardi, Alessandra, Cipriani, Paola, Marola, Laura, Grimaldi, Alessandro, Giacomelli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831386/ https://www.ncbi.nlm.nih.gov/pubmed/31415347 http://dx.doi.org/10.1097/MD.0000000000016399 |
Ejemplares similares
-
Comparative efficacy and safety of JAK inhibitors and leflunomide in rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Zhang, Xiaogang, et al.
Publicado: (2022) -
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study
por: Ruscitti, Piero, et al.
Publicado: (2017) -
Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Qi, Weiyu, et al.
Publicado: (2021) -
Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review
por: Keng, Li-Ta, et al.
Publicado: (2016) -
Incidence of venous thromboembolism in rheumatoid arthritis, results from a “real-life” cohort and an appraisal of available literature
por: Conforti, Alessandro, et al.
Publicado: (2021)